A fatal case of healthcare associated Crimean-Congo haemorrhagic fever with severe disease and multi-organ failure

Journal of Infection

Volumn 72, Issue 2, 2016, Pages 253-255

  Sunbul, Mustafa ^a   Esen, Saban ^a   Fletcher, Tom E ^a,b   Dilek, Ahmet ^a   Guler, Nil ^a   Beeching, Nick J ^b,c   Leblebicioglu, Hakan ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; INOTROPIC AGENT; MEROPENEM; RIBAVIRIN; STEROID; VIRUS ANTIBODY;

ADULT; ASCITES; ATRIAL FIBRILLATION; CARDIOVERSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRIMEAN CONGO HEMORRHAGIC FEVER; CRYOPRECIPITATE; DEATH; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; FATALITY; FEVER; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEMODIALYSIS; HEMOPHAGOCYTIC SYNDROME; HOSPITAL INFECTION; HUMAN; HYPOTENSION; KIDNEY DISEASE; LETTER; LOADING DRUG DOSE; LUNG INFILTRATE; MALE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; MYALGIA; NEEDLESTICK INJURY; PLASMAPHERESIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; RESIDENT; SEPTIC SHOCK; SOMNOLENCE; THORAX DRAINAGE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TONIC CLONIC SEIZURE; VIRUS LOAD;

ANTIBODIES, VIRAL; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MULTIPLE ORGAN FAILURE;

EID: 84960456419     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.10.005     Document Type: Letter

References (10)

1. Grillet G., Marjanovic N., Diverrez J.-M., Tattevin P., Tadié J.-M., L'Her E. Intensive care medical procedures are more complicated, more stressful, and less comfortable with Ebola personal protective equipment: a simulation study. J Infect 2015 Sep 21, 71(6):703-706. pii: S0163-4453(15)00281-9. 10.1016/j.jinf.2015.09.003.
2. Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents 2010 Nov, 36(Suppl 1):S43-S46.
3. Conger N.G., Paolino K.M., Osborn E.C., Rusnak J.M., Günther S., Pool J., et al. Health care response to CCHF in US soldier and nosocomial transmission to health care. Emerg Infect Dis 2015, 21(1):23-31.
4. Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K.A. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 2011, 66:1215-1222. (April).
5. Kubar A., Haciomeroglu M., Ozkul A., Bagriacik U., Akinci E., Sener K., et al. Prompt administration of crimean-congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis 2011, 64(5):439-443.
6. Meço B.C., Memikoğlu O., Ilhan O., Ayyildiz E., Gunt C., Unal N., et al. Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever. Transfus Apher Sci 2013 Jun, 48(3):331-334.
7. Leblebicioglu H., Bodur H., Dokuzoguz B., Elaldi N., Guner R., Koksal I., et al. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector-Borne Zoonotic Dis 2012, 12(9):805-811.
8. Gozel M.G., Dokmetas I., Oztop A.Y., Engin A., Elaldi N., Bakir M. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int J Infect Dis 2013, 17(11):1046-1050.
9. Oestereich L., Rieger T., Neumann M., Bernreuther C., Lehmann M., Krasemann S., et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis 2014 May, 8(5):e2804.
10. Médecins Sans Frontières Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea (accessed September 8th, 2015). http://www.msf.org/article/preliminary-results-jiki-clinical-trial-test-efficacy-favipiravir-reducing-mortality.